(11bR)-N-Benzyl-N-methyldinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine, 97.0%, 1g

(R)-4-Bromo-1-(pyrrolidin-3-yl)-1H-pyrazole hydrochloride, 250mg

3-(1,2,3-Thiadiazol-4-yl)phenol, 97%, 1g

4-fluoro-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine, 97.0%, 250mg

(1R,2S)-2-[N-Benzyl-N-(mesitylenesulfonyl)amino]-1-phenylpropyl Propionate [Reagent for anti-selective asymmetric aldol reaction]>98.0%(HPLC)1g

3-Amino-6-bromopyridin-2(1H)-one hydrobromide, 95.0%, 250mg

7-METHYL-4H,5H,6H,7H-PYRAZOLO[1,5-A]PYRAZINE, 95.0%, 100mg

Heneicosane>99.0%(GC)5g

1-Phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine hydrochloride, 95.0%, 100mg

4-Bromo-2-nitrophenol>98.0%(GC)(T)25g

L-prolyl-L-tyrosine, 98%, 100mg

N-(2,4-Dimethoxybenzyl)-1,2,4-thiadiazol-5-amine, 95.0%, 10g

(1R,5R)-3-methyl-3,6-diazabicyclo[3.2.0]heptane; bis(trifluoroacetic acid), 95.0%, 500mg